NRC Health (NRC) Fair Value 2026

NRC · Health Information Services ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

7.0 /10

32 fundamental signals · 9 models active

Value Trap Risk

LOW (34/100)

Quick Summary — As of 2026-08-27, NRC Health (NRC) trades at $22.01, versus a $13.68 median fair value across its 9 active models — 37.9% below the current price. QOC: 7.0/10. Value Trap Risk: 34/100 (LOW). 9/13 models active. Within that set, the Bayesian DCF component alone returns $3.40.

Key Facts

Ticker
NRC
Price
$22.01
Quality Score
7.0/10
Value Trap Risk
34/100
Models Active
9/13
Last Updated
Strength: 9 independent models provide multi-angle coverage
Risk: Majority of models suggest overvaluation

Is NRC Health (NRC) Undervalued or Overvalued in 2026?

According to CirclFi’s 9-model valuation engine, NRC Health (NRC) appears overvalued as of : the median of 9 independent fair value estimates is $13.68, 37.9% below the current price of $22.01. Estimates range from $2.06 to $38.34. NRC scores 7.0/10 on fundamental quality and 34/100 on value-trap risk.

For context, the median US equity CirclFi rates trades at an implied -23.7% versus its own 13-model consensus, across 3,801 rated companies as of 2026-08-27. NRC’s -37.9% gap is wider than that market norm, and the Health Information Services sector median is +4.5%. Full market index →

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy NRC Health Stock in 2026? →

What Fair Value Does Each Model Give NRC?

9 Intrinsic Value Models vs. Current Price ($22.01)

Core Models (Unlocked)
Model Fair Value Upside
Intrinsic · High Conviction
 $3.40 -84.6%
Intrinsic · High Conviction
 $11.89 -46.0%
Ensemble · Low Conviction
 $13.68 -37.9%
Intrinsic · High Conviction
 $2.06 -90.7%
Unlock the Full Matrix

Access 5 additional models including Markov DDM, Regime Cross-Sectional, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 9 Models →

Cancel anytime · No contracts · Instant access

What Is NRC's Fair Value Range?

Spread across 9 independent models · $2.06 to $38.34

CirclFi's 9 active models place NRC Health (NRC) between $2.06 and $38.34 per share, a spread of 265% of the median. The median of that range — $13.68 — is the fair value CirclFi publishes for NRC, against a current price of $22.01.

Low · EROICHigh · Regime Cross
$2.06median $13.68$38.34
Where the range comes from
Most bearish modelEROIC Spread$2.06
Most bullish modelRegime Cross-Sectional$38.34
Model agreement2 bullish · 6 bearishwide

A band this wide is itself the finding. When independent methods land far apart, they are reading a business whose value depends heavily on which lens you apply — volatile earnings, heavy reinvestment, or an asset base that cash-flow and asset-based methods score differently. That disagreement is information: it says the choice of method matters more than usual for NRC. Treat the median as one reading among several and compare the individual models below before acting.

Every figure above is one model's standalone output on NRC, not a CirclFi price target. How each model works →

What Is NRC Health (NRC) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, the balance of valuation evidence tilts cautious on NRC Health at its current price of $22.01. The median intrinsic value is estimated at $13.68 (-37.9% vs price), with 6 models flagging overvaluation risk. Model dispersion is worth noting: Regime Cross targets $38.34 (+74.2%), versus EROIC at $2.06 (-90.7%). This +164.9% range highlights the importance of multi-model analysis rather than relying on any single methodology. Among models with highest confidence, Bayesian DCF, EPV lean bearish — adding weight to the bearish side of the thesis.

What Do the Models Say About NRC?

9 of 13 models are currently active for NRC. Of these, 2 models suggest upside while 7 models suggest overvaluation. Taken together, their median fair value for NRC is $13.68 — the figure CirclFi publishes as this stock's fair value. One component of that median, the Bayesian DCF, returns $3.40 on its own, implying -84.6% downside from the current price. See which stocks rank higher →

How Does NRC Rank in Health Information Services?

Among 55 Health Information Services stocks, NRC ranks #21 by Quality of Company score. CirclFi's QOC score of 7.0/10 evaluates 32 fundamental signals. A score of 7.0 indicates above-average quality.

See all Most Undervalued Health Information Services Stocks →

NRC Health operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.

Is NRC a Value Trap?

CirclFi's Value Trap algorithm assigns NRC a score of 34/100 (LOW). This indicates low risk. The financial profile does not exhibit typical value trap warning signs. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

9 of 13 models are active for NRC Health. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi 32-factor quality framework, NRC Health's fundamental quality profile registers 7.0/10. This respectable score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.

The gap between the most bullish and bearish model spans +164.9% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every NRC valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across NRC's 9 active models, average confidence is 51%. Moderate confidence indicates reasonable fit.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy NRC Health Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Health Information Services Stocks Should You Also Analyze?

11 related Health Information Services stocks with 13-model coverage

SDGRSchrödinger, Inc.QOC 7.1DHDefinitive Healthcare Corp.QOC 7.0BTSGBrightSpring Health Services, Inc.QOC 7.2TALKTalkspace IncQOC 7.0TDOCTeladoc Health, Inc.QOC 7.3WEAVWeave Communications, Inc.QOC 6.6PBSVPharma-Bio Serv, Inc.QOC 5.9MSPRMSP Recovery, Inc.QOC 4.7PHRPhreesia, Inc.QOC 8.4DOCSDoximity, Inc.QOC 9.6HQYHealthEquity, Inc.QOC 9.5

Read investment analysis: SDGR · DH · BTSG · TALK · TDOC · WEAV · PBSV · MSPR · PHR · DOCS · HQY

Which Other Stocks Have a Similar Quality Score to NRC?

7 companies across all industries closest to NRC’s Quality of Company score of 7.0/10.

CSPICSP Inc.QOC 7.0WECWEC Energy Group, Inc.QOC 7.0VIRCVirco Mfg. CorporationQOC 7.0CTOSCustom Truck One Source, Inc.QOC 7.0ONDSOndas Inc.QOC 7.0AOUTAmerican Outdoor Brands, Inc.QOC 7.0NVDANVIDIA CorporationQOC 10.0

Read investment analysis: CSPI · WEC · VIRC · CTOS · ONDS · AOUT · NVDA

Where Does NRC Sit in CirclFi's Health Information Services Rankings?

NRC is ranked against every other Health Information Services stock CirclFi covers in each of these screens.

See all Health Information Services stocks ranked →

What Else Do Investors Ask About NRC Health’s Valuation?

What is NRC Health's intrinsic value in 2026?

CirclFi puts NRC Health (NRC)'s intrinsic value at $13.68 — the median of 9 independent model estimates as of 2026-08-27, ranging from $2.06 to $38.34. One component of that median, the Bayesian DCF, runs 10,000 Monte Carlo simulations with jump-diffusion and returns $3.40 on its own. The Quality of Company score is 7.0/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is NRC overvalued or undervalued right now?

At $22.01, 2 of 9 active models suggest NRC may be undervalued, while 7 indicate potential overvaluation. The median of all 9 fair value estimates is $13.68, 37.9% below the current price of $22.01 — a consensus view that NRC is overvalued. The assessment depends on which methodology best fits NRC Health's business model in Health Information Services.

What does a Quality of Company score of 7.0 mean for NRC?

NRC Health's QOC of 7.0/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores above 7 indicate strong fundamentals and disciplined management.

How many valuation models does CirclFi run on NRC?

CirclFi analyzes NRC with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 9 of 13 are active for this stock. Read the full methodology →

Which valuation models are most bullish and most bearish on NRC?

Of the 9 models currently active on NRC, Regime Cross-Sectional is the most bullish at $38.34 per share, and EROIC Spread is the most bearish at $2.06. CirclFi's published fair value for NRC is the median of that range, $13.68, not either extreme. The gap between the two ends equals 265% of the median — a wide spread, meaning the methods genuinely disagree and the median should carry less weight. Browse stocks by value-trap risk →

Is NRC a value trap in 2026?

NRC Health's Value Trap score is 34/100 (LOW). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap.

Cite this analysis — “According to CirclFi’s 9-model valuation engine, NRC Health (NRC) has a median fair value of $13.68 — 37.9% below the current price of $22.01 — as of 2026-08-27.” Source: circlfi.com/stock/NRC/ · Methodology
Primary sources for this NRC valuation
  • Financial statements: NRC Health 10-K and 10-Q filings on SEC EDGAR (CIK 0000070487) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for NRC as of ; valuations recomputed .

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 9 mathematical frameworks give you clarity on NRC.

Unlock All 9 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access

5 models hidden for NRC Unlock All 9 — $39/mo